Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival

Annals of Thoracic Surgery

Volumn 70, Issue 6, 2000, Pages 1826-1831

  Bueno, Raphael ^a   Richards, William G ^a   Swanson, Scott J ^a   Jaklitsch, Michael T ^a   Lukanich, Jeanne M ^a   Mentzer, Steven J ^a   Sugarbaker, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; SURVIVAL RATE;

EID: 0034532385     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01585-X     Document Type: Article

References (16)

1. Cancer statistics, 2000
2. Revisions in the international system for staging lung cancer
3. The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung: A commentary
4. Combined modality therapy of lung cancer
5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935
6. Results of Cancer and Leukemia Group B Protocol 8935: A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer
7. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II Study 8805
8. Induction chemotherapy with/without radiation followed by surgery in stage III non-small-cell lung cancer
9. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer
10. The role of induction (neoadjuvant) chemotherapy in stage IIIA NSCLC
11. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer
12. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer
13. Prognosis and survival in resected lung carcinoma based on the new international staging system
14. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
15. Extended resection for higher-stage non-small-cell lung cancer
16. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach